Several mechanisms have been suggested for the induction of immune suppression by tumors, including induction of Tregs, myeloid-derived suppressor cells, tumor-associated macrophages and tolerogenic DCs; secretion of immunosuppressive soluble factors; and activation of negative regulatory pathways such as CTLA-4 and PD-1. This evidence concerns the gene CTLA4 and neoplasm.